The Effect of Botulinum Toxin Injection After Hemorrhoidectomy in Pain Control.
1 other identifier
interventional
60
1 country
1
Brief Summary
Hemorrhoids are a common disease in the general population. Its prevalence is estimated to be 5-36 % and more prevalent in western countries . Half of people older than 50 years of age will suffer from hemorrhoids in a period of their life, of which only 5-10% will require surgical intervention while most of the remainders become asymptomatic and improved with the conservative treatment. Conservative treatment in the form of diet modification as well as some medical treatment, is usually effective. On the other hand, a few patients require surgical intervention. Surgery is indicated for those not responding to conservative management, those with grade III, and grade IV hemorrhoids. Surgical treatment is the only curative method for hemorrhoidal disease and indicated for advanced and complicated disease. The most radical operations with the best results are the Milligan-Morgan and Ferguson hemorrhoidectomy . However, the major concern of hemorrhoidectomy is the post-operative pain that occurs in 20-40 % of patients and it is considered the main cause of refusing surgery. The cause of postoperative pain is multifactorial, including the type of anesthesia , hemorrhoidectomy technique. and spasm of the internal anal sphincter (IAS) that becomes exposed after hemorrhoidectomy. The spasm of the IAS is considered the target to relieve pain post operatively. Lateral internal sphincterotomy (LIS) is widely used as an adjunct to relieve pain post hemorrhoidectomy as it release the spasm of the sphincter and subsequently relieve pain. However, this procedure is not accepted by many surgeons due to its recorded complications as bleeding and mild degree of fecal incontinence, so its role following hemorrhoidectomy is still controversial. On the other hand, the spasm of the anal sphincter can be abolished by injection of the botulinum toxin which acts on the acetylcholine receptor and consequently temporary muscle paralysis occurs that is followed by decreased pain and wound healing. Our hypothesis is botulinum toxin relaxes the internal sphincter, so prevent its spasm and so reducing the pain and promoting wound healing more rapidly.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pain
Started Dec 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedFirst Submitted
Initial submission to the registry
May 26, 2023
CompletedFirst Posted
Study publicly available on registry
June 6, 2023
CompletedJune 8, 2023
June 1, 2023
12 months
May 26, 2023
June 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-operative pain
according to the visual analogue scale (VAS), which contain 10 degrees, the lower the degree , the lower the score this means less pain.
2weeks
Secondary Outcomes (1)
Time taken to return to daily activities in days.
4-6weeks
Study Arms (3)
Botox injection post hemorridectomy
ACTIVE COMPARATORafter piles excision this group will be subjected to botox injection in the internal sphincter
Hemorridectomy alone
NO INTERVENTIONJust hemorridectomy without botox injection(control group)
Hemorridectomy plus internal sphincterotomy
ACTIVE COMPARATORafter piles excision patients will undergo internal sphincterotomy
Interventions
one group will have botox injection in the internal sphincter
this group will have internal sphincterotomy
Eligibility Criteria
You may qualify if:
- Both sexes,
- aged between 18 and 70 years old.
- Grade III and IV hemorrhoids.
- Those with failed conservative treatment.
You may not qualify if:
- surgically unfit patients due to multiple comorbidities,
- patients who need emergency operation for complicated hemorrhoids,
- patients with partial rectal prolapse
- patients with rectal varices due to portal hypertension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ahmad
Al Mansurah, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- consultant and lecturer of general surgery
Study Record Dates
First Submitted
May 26, 2023
First Posted
June 6, 2023
Study Start
December 1, 2021
Primary Completion
November 30, 2022
Study Completion
February 1, 2023
Last Updated
June 8, 2023
Record last verified: 2023-06